Isoniazid and liver safety in tuberculosis treatment
Part of Digestive system, Infections clinical trials.
This study looks at how often isoniazid, a medicine used to treat tuberculosis, causes liver damage in everyday practice, and what factors might predict that risk. If you are taking or have taken isoniazid, this research may help doctors understand your risk and improve safety for other patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with tuberculosis (TB) or latent TB and your treatment includes a medicine called isoniazid.
- Before starting isoniazid, your liver tests (ALT, AST, and bilirubin) were within normal limits, and you had no symptoms of liver problems.
- You are not pregnant or breastfeeding.
- You do not have pre-existing liver disease, and you are not taking other medications that can harm the liver.
- You agree to sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how anti-tuberculosis (TB) medicines move into breast milk and stay in the body of breastfeeding women. The goal is to learn more about the safety and dosing of these drugs for mothers and their babies.
This study tests ways to help people who live with or are close to someone with tuberculosis get medicine to prevent them from getting sick. It aims to improve how many people start and finish this preventive treatment in Tajikistan and Tanzania.
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This trial tests inhaled isoniazid (medicine) given through a nebulizer to see how well it works and how safe it is. It's for people being treated for tuberculosis.
This trial tests whether two natural supplements—silymarin (milk thistle) and n-acetylcysteine—can protect the liver from damage caused by tuberculosis medications. If you qualify, you will receive one of these supplements along with your TB treatment to see which one helps prevent liver problems.
Hear when a new Tuberculosis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.